OBJECTIVE: To determine if reduction in nitric oxide bioactivity contributes to the physiological instability that occurs after brain death and, if so, to also determine in this setting whether administration of a renitrosylating agent could improve systemic physiological status. BACKGROUND: Organ function after brain death is negatively impacted by reduced perfusion and increased inflammation; the magnitude of these responses can impact post-graft function. Perfusion and inflammation are normally regulated by protein S-nitrosylation but systemic assessments of nitric oxide bioactivity after brain death have not been performed. METHODS: Brain death was induced in instrumented swine by inflation of a balloon catheter placed under the cranium. The subjects were then serially assigned to receive either standard supportive care or care augmented by 20 ppm of the nitrosylating agent, ethyl nitrite, blended into the ventilation circuit. RESULTS: Circulating nitric oxide bioactivity (in the form of S-nitrosohemoglobin) was markedly diminished 10 hours after induction of brain death-a decline that was obviated by administration of ethyl nitrite. Maintenance of S-nitrosohemoglobin was associated with improvements in tissue blood flow and oxygenation, reductions in markers of immune activation and cellular injury, and preservation of organ function. CONCLUSIONS: In humans, the parameters monitored in this study are predictive of post-graft function. As such, maintenance of endocrine nitric oxide bioactivity after brain death may provide a novel means to improve the quality of organs available for donation.
OBJECTIVE: To determine if reduction in nitric oxide bioactivity contributes to the physiological instability that occurs after brain death and, if so, to also determine in this setting whether administration of a renitrosylating agent could improve systemic physiological status. BACKGROUND: Organ function after brain death is negatively impacted by reduced perfusion and increased inflammation; the magnitude of these responses can impact post-graft function. Perfusion and inflammation are normally regulated by protein S-nitrosylation but systemic assessments of nitric oxide bioactivity after brain death have not been performed. METHODS:Brain death was induced in instrumented swine by inflation of a balloon catheter placed under the cranium. The subjects were then serially assigned to receive either standard supportive care or care augmented by 20 ppm of the nitrosylating agent, ethyl nitrite, blended into the ventilation circuit. RESULTS: Circulating nitric oxide bioactivity (in the form of S-nitrosohemoglobin) was markedly diminished 10 hours after induction of brain death-a decline that was obviated by administration of ethyl nitrite. Maintenance of S-nitrosohemoglobin was associated with improvements in tissue blood flow and oxygenation, reductions in markers of immune activation and cellular injury, and preservation of organ function. CONCLUSIONS: In humans, the parameters monitored in this study are predictive of post-graft function. As such, maintenance of endocrine nitric oxide bioactivity after brain death may provide a novel means to improve the quality of organs available for donation.
Authors: Richard L Auten; Stanley N Mason; Mary H Whorton; William R Lampe; W Michael Foster; Ronald N Goldberg; Bo Li; Jonathan S Stamler; Kathryn M Auten Journal: Am J Respir Crit Care Med Date: 2007-05-03 Impact factor: 21.405
Authors: Valeria R Mas; Kellie J Archer; Kenneth Yanek; Catherine I Dumur; Maria I Capparuccini; Martin J Mangino; Anne King; Eric M Gibney; Robert Fisher; Marc Posner; Daniel Maluf Journal: Transplantation Date: 2008-02-27 Impact factor: 4.939
Authors: Alfred Hausladen; Ruslan Rafikov; Michael Angelo; David J Singel; Evgeny Nudler; Jonathan S Stamler Journal: Proc Natl Acad Sci U S A Date: 2007-02-07 Impact factor: 11.205
Authors: James D Reynolds; Gregory S Ahearn; Michael Angelo; Jian Zhang; Fred Cobb; Jonathan S Stamler Journal: Proc Natl Acad Sci U S A Date: 2007-10-11 Impact factor: 11.205
Authors: Jason Moore; Kay Tan; Paul Cockwell; Hari Krishnan; Dawn McPake; Andrew Ready; Steve Mellor; Ahmed Hamsho; Simon Ball; Graham Lipkin; Richard Borrows Journal: Nephrol Dial Transplant Date: 2007-06-07 Impact factor: 5.992
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Valéry Blasco; Marc Leone; Julien Bouvenot; Alain Geissler; Jacques Albanèse; Claude Martin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: James D Reynolds; Trevor Jenkins; Faisal Matto; Ryan Nazemian; Obada Farhan; Nathan Morris; John M Longphre; Douglas T Hess; Richard E Moon; Claude A Piantadosi; Jonathan S Stamler Journal: Clin Pharmacol Ther Date: 2018-01-17 Impact factor: 6.875
Authors: Camille J Roche; Maria B Cassera; David Dantsker; Rhoda Elison Hirsch; Joel M Friedman Journal: J Biol Chem Date: 2013-06-17 Impact factor: 5.157
Authors: Ryan Nazemian; Maroun Matta; Amer Aldamouk; Lin Zhu; Mohamed Awad; Megan Pophal; Nicole R Palmer; Tonya Armes; Alfred Hausladen; Jonathan S Stamler; James D Reynolds Journal: Sci Rep Date: 2022-04-22 Impact factor: 4.379